TP53 and cancer: These observations are novel and are consistent with the idea that the disruption of energetic stress-induced checkpoint through the loss of the ATM function, as is the case in AT cells, or the loss of p53 or IFI16 function, as is the case in certain human cancers, may provide a growth advantage to cells under energetic stress.